With an extensive background in molecular biology, translational research, and drug development, Doug assists biotechnology, chemical, and pharmaceutical clients in the patent filing and prosecution process.
Doug DiGirolamo has valuable consulting experience advising entrepreneurs, startups, and established companies in non-dilutive funding and commercialization strategies across a diverse range of subject areas, including drug development, medical device development, digital health, cybersecurity, and economic development. He has broad scientific expertise through his past continuously NIH-funded academic research career that encompassed musculoskeletal biology, cancer biology, endocrinology, and biomedical engineering. Doug has demonstrated success in innovative project design and dynamic management across subject areas and multidisciplinary teams.
The University of Alabama at Birmingham (Ph.D., 2008)